Global Artificial Intelligence (AI) Radiology Tool market size is expected to reach $3.4 billion by 2029 at 18%, segmented as by diagnostic radiology, ai for image interpretation (detecting fractures, tumors, or abnormalities)
Read More
Global Appendicitis Treatment market size is expected to reach $5.72 billion by 2029 at 6.8%, segmented as by acute appendicitis, surgical treatment (appendectomy), non-surgical treatment (antibiotics and observation)
Read More
Global Aplastic Anemia market size is expected to reach $8.84 billion by 2029 at 5.9%, segmented as by disease type, acquired aplastic anemia, inherited bone marrow failure syndromes
Read More
Global Antidiabetics market size is expected to reach $130.12 billion by 2029 at 11.3%, segmented as by insulin, rapid-acting insulin, short-acting insulin, intermediate-acting insulin, long-acting insulin, premixed insulin
Read More
Global Anosmia market size is expected to reach $5.65 billion by 2029 at 9.7%, segmented as by idiopathic anosmia, partial idiopathic anosmia, complete idiopathic anosmia
Read More
Global Angina market size is expected to reach $14.44 billion by 2029 at 6.1%, segmented as by angina pectoris, stable angina, chronic stable angina, effort-induced angina, variant or microvascular angina
Read More
Global Anesthesia Circuits And Regional Anesthesia Disposables market size is expected to reach $1.72 billion by 2029 at 2.9%, segmented as by anesthesia circuits, adult anesthesia circuits, pediatric anesthesia circuits
Read More
Global Amoxicillin market size is expected to reach $5.63 billion by 2029 at 3.5%, segmented as by penicillin, penicillin g, penicillin v, extended-spectrum penicillins (amoxicillin), beta-lactam antibiotics
Read More
Global Amblyopia market size is expected to reach $5.84 billion by 2029 at 4.6%, segmented as by strabismus amblyopia, congenital strabismus amblyopia, acquired strabismus amblyopia, non-paralytic strabismus amblyopia, paralytic strabismus amblyopia
Read More
Global Alpers Disease Treatment market size is expected to reach $1.8 billion by 2029 at 5.7%, segmented as by anticonvulsant drugs, valproic acid, levetiracetam, lamotrigine, topiramate, clonazepam, phenobarbital, others
Read More